drugset / Trial / NCT00426036
Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will assess the influence of severe renal impairment on the pharmacokinetics of licarbazepine and its glucuronide conjugate after single oral administration in healthy subjects and in subjects with stable impaired renal function.
Timeline
- Start
- 2006-06
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Licarbazepine | Small molecule | 500 mg | Oral |
Indications
No indication recorded.